title: Managing interactions between cognitive enhancers and other psychotropics.
abstract: Polypharmacy is common in psychiatry. Usage of cognitive enhancers is increasing in the psychiatric population. Many clinicians are not familiar with these new psychoactive compounds. This paper reviews the potential drug-drug interactions when these cognitive enhancers are used together with psychotropic drugs and their confounding effects on diagnosis and clinical management.
authors.affiliation: aDepartment of Psychiatry, School of Medicine, University of California, Irvine, California, USA bDepartment of Pharmacology, National University of Ireland, Galway, Ireland cInstitute of Brain Medicine, Hong Kong, China.
authors.forename: Siu W
authors.initials: SW
authors.lastname: Tang
authors.forename: Wayne H
authors.initials: WH
authors.lastname: Tang
authors.forename: Brian E
authors.initials: BE
authors.lastname: Leonard
mesh_terms: D000818:Animals; D004347:Drug Interactions / Q000502:physiology*; D018565:Food-Drug Interactions / Q000502:physiology; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000378:metabolism*; D018697:Nootropic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019338:Polypharmacy; D011619:Psychotropic Drugs / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D018697:Nootropic Agents; D011619:Psychotropic Drugs